用於脂肪肝病和脂肪性肝炎治療的GLP-1/胰高血糖素受體激動劑农业专利-农业学术服务平台

发明人:: KANNT, AIMO,坎特　艾摩,BIELOHUBY, MAXIMILIAN,毕洛哈比　麦斯米兰,畢洛哈比　麥斯米蘭,ELVERT, RALF,埃尔韦特　拉尔夫,埃爾韋特　拉爾夫,WAGNER, MICHAEL,瓦格纳　麦克,瓦格納　麥克,BOSSART, MARTIN,波沙特　马汀,波沙特　馬汀,HAACK, TORSTEN,哈克　托斯腾,哈克　托斯騰,KEIL, STEFANIE

摘要：: The present invention relates to the medical use of specific GLP-1/glucagon receptor agonists in the prevention and/or treatment of metabolic liver disease, particularly non-alcoholic fatty liver disease (NAFLD), more particularly non-alcoholic fatty liver (NAFL), non-alcoholic steatohepatitis (NASH) and/or NAFLD-associated liver fibrosis.本發明關於特定的GLP-1/胰高血糖素受體激動劑在預防和/或治療代謝性肝病，具體地非酒精性脂肪肝病(NAFLD)，更具體地非酒精性脂肪肝(NAFL)、非酒精性脂肪性肝炎(NASH)和/或NAFLD相關肝纖維化中的醫學用途。